Biohaven Pharmaceutical Holding Company Ltd
NYSE:BHVN

Watchlist Manager
Biohaven Pharmaceutical Holding Company Ltd Logo
Biohaven Pharmaceutical Holding Company Ltd
NYSE:BHVN
Watchlist
Price: 50.36 USD -3.95% Market Closed
Market Cap: 5B USD
Have any thoughts about
Biohaven Pharmaceutical Holding Company Ltd?
Write Note

Income Statement

Earnings Waterfall
Biohaven Pharmaceutical Holding Company Ltd

Revenue
0 USD
Operating Expenses
-781.3m USD
Operating Income
-781.3m USD
Other Expenses
34.7m USD
Net Income
-746.6m USD

Income Statement
Biohaven Pharmaceutical Holding Company Ltd

Rotate your device to view
Income Statement
Currency: USD
Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024
Revenue
Revenue
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
Operating Income
Operating Expenses
(568)
(556)
(453)
(496)
(436)
(542)
(781)
Selling, General & Administrative
(131)
(126)
(120)
(120)
(63)
(76)
(80)
Research & Development
(437)
(430)
(333)
(376)
(373)
(466)
(701)
Operating Income
(568)
N/A
(556)
+2%
(453)
+19%
(496)
-9%
(436)
+12%
(542)
-24%
(781)
-44%
Pre-Tax Income
Interest Income Expense
0
0
0
0
0
0
0
Total Other Income
(2)
6
12
17
27
23
31
Pre-Tax Income
(570)
N/A
(550)
+4%
(441)
+20%
(479)
-9%
(410)
+14%
(519)
-27%
(750)
-45%
Net Income
Tax Provision
(0)
6
10
14
1
2
4
Income from Continuing Operations
(570)
(544)
(431)
(465)
(408)
(517)
(747)
Net Income (Common)
(570)
N/A
(544)
+5%
(431)
+21%
(465)
-8%
(408)
+12%
(517)
-27%
(747)
-44%
EPS (Diluted)
-8.36
N/A
-7.97
+5%
-6.31
+21%
-6.8
-8%
-5.73
+16%
-6.33
-10%
-8.5
-34%

See Also

Discover More